albireopharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://albireopharma.com/sitemap_index.xml # --------------------------- # END YOAST | ||
Meta Tags
| Title | Albireo Pharma - Providing Hope for |
| Description | Breaking We are harnessing the power of bile acid modulation to pursue potential new treatment options to improve the lives of people living with liver |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 35.190.22.133 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
albireopharma.com Valuation
|
US$28,498,777
Last updated: 2023-05-07 10:15:38
albireopharma.com has Semrush global rank of 371,395. albireopharma.com has an estimated worth of US$ 28,498,777, based on its estimated Ads revenue. albireopharma.com receives approximately 3,288,321 unique visitors each day. Its web server is located in United States, with IP address 35.190.22.133. According to SiteAdvisor, albireopharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$28,498,777 |
| Daily Ads Revenue | US$26,307 |
| Monthly Ads Revenue | US$789,197 |
| Yearly Ads Revenue | US$9,470,363 |
| Daily Unique Visitors | 219,222 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| albireopharma.com. | A | 3597 | IP: 35.190.22.133 |
| albireopharma.com. | NS | 3600 | NS Record: zitacdns01.zitac.net. |
| albireopharma.com. | NS | 3600 | NS Record: zitacdns02.zitac.net. |
| albireopharma.com. | MX | 3600 | MX Record: 10 albireopharma-com.mx1.staysecuregroup.com. |
| albireopharma.com. | MX | 3600 | MX Record: 20 albireopharma-com.mx2.staysecuregroup.net. |
| albireopharma.com. | TXT | 3600 | TXT Record: QRkFoXa9lzbAQ2vt |
| albireopharma.com. | TXT | 3600 | TXT Record: apple-domain-verification=aRvwQNfF612ueLwQ |
| albireopharma.com. | TXT | 3600 | TXT Record: knowbe4-site-verification=7f2ce7cd3753f38871f55af9a9e59a11 |
| albireopharma.com. | TXT | 3600 | TXT Record: v=spf1 include:mailanyone.net a:zmail.zweb.zitac.net a:mailanyone.net ip4:193.15.103.65 ip4:193.15.103.66 ip4:208.185.229.0/24 ip4:208.185.235.0/24 ip4:148.59.108.0/23 ip4:148.59.106.0/23 ip4:5.253.0.0/24 ~all |
| albireopharma.com. | TXT | 3600 | TXT Record: aRvwQNfF612ueLwQ |
| albireopharma.com. | TXT | 3600 | TXT Record: MS=ms62241793 |
HtmlToTextCheckTime:2023-05-07 10:15:38
| Albireo Appoints Paul Streck, M.D., as CMO & Craig Hopkinson, M.D., to Board of Directors. Clinical Trials Partnerships Media Careers Contact Science & Medicine Scientific Focus Pipeline Medicines Patients & Families Diseases & Conditions Patient Resources Clinical Trials Access to Bylvay® (odevixibat) Responsibility Access Disclosures Investors Press Releases Publications Financials & Filings + Science & Medicine Scientific Focus Pipeline Medicines Patients & Families Diseases & Conditions Clinical Trials Patient Resources Managed Access Responsibility Access Disclosures Investors Press Releases Publications Financials & Filings Careers Media Contact Partnerships Breaking News Ipsen announces completion of acquisition of Albireo, strengthening rare disease portfolio with promising therapeutics for pediatric and adult rare liver diseases. Read More PIPELINE Investors Patients & Families Science & Medicine We are harnessing the power of bile acid modulation to pursue potential new |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Wed, 27 Oct 2021 20:08:32 GMT Server: Apache Location: https://albireopharma.com/ Content-Type: text/html; charset=iso-8859-1 Via: 1.1 google Set-Cookie: GCLB=CLuB9f7Eg8iWhQE; path=/; HttpOnly; expires=Wed, 27-Oct-2021 21:08:36 GMT Transfer-Encoding: chunked HTTP/2 200 date: Wed, 27 Oct 2021 20:08:32 GMT server: Apache set-cookie: CONCRETE5=fd1f4d389aad1a66f8eb4a963aa82182; path=/; HttpOnly set-cookie: GCLB=CPKOluOzlMWT8QE; path=/; HttpOnly; expires=Wed, 27-Oct-2021 21:08:36 GMT cache-control: no-cache, private x-frame-options: SAMEORIGIN content-type: text/html; charset=UTF-8 via: 1.1 google alt-svc: clear |
albireopharma.com Whois Information
Domain Name: ALBIREOPHARMA.COM Registry Domain ID: 963387263_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-07-04T04:16:34Z Creation Date: 2007-05-07T17:13:32Z Registry Expiry Date: 2024-05-07T17:13:32Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: ZITACDNS01.ZITAC.NET Name Server: ZITACDNS02.ZITAC.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-15T15:48:10Z <<< |